| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3059461 | F | Antibacterial activity against Hofmanni bacterium assessed as zone of inhibition after 18 to 24 hr by disc diffusion method relative to gatifloxacin | Hofmanni bacterium | 5 | organism-based format | Scientific Literature | ||
| 2. | ALA3056950 | F | Antibacterial activity against Hofmanni bacterium assessed as concentration required to obtain a zone of inhibition of 20 mM after 18 to 24 hr by disc diffusion method | Hofmanni bacterium | 6 | organism-based format | Scientific Literature | ||
| 3. | ALA3056951 | F | Antibacterial activity against Hofmanni bacterium assessed as concentration required to obtain a zone of inhibition of 5 mM after 18 to 24 hr by disc diffusion method | Hofmanni bacterium | 6 | organism-based format | Scientific Literature | ||
| 4. | ALA3056952 | F | Antibacterial activity against Hofmanni bacterium assessed as concentration required to obtain a zone of inhibition of 10 mM after 18 to 24 hr by disc diffusion method | Hofmanni bacterium | 6 | organism-based format | Scientific Literature | ||
| 5. | ALA3056953 | F | Antibacterial activity against Shigella typhi assessed as zone of inhibition after 18 to 24 hr by disc diffusion method relative to gatifloxacin | Shigella | 5 | organism-based format | Scientific Literature | ||
| 6. | ALA3057475 | F | Antibacterial activity against Shigella typhi assessed as concentration required to obtain a zone of inhibition of 20 mM after 18 to 24 hr by disc diffusion method | Shigella | 6 | organism-based format | Scientific Literature | ||
| 7. | ALA3057476 | F | Antibacterial activity against Shigella typhi assessed as concentration required to obtain a zone of inhibition of 10 mM after 18 to 24 hr by disc diffusion method | Shigella | 6 | organism-based format | Scientific Literature | ||
| 8. | ALA3057477 | F | Antibacterial activity against Shigella typhi assessed as concentration required to obtain a zone of inhibition of 5 mM after 18 to 24 hr by disc diffusion method | Shigella | 6 | organism-based format | Scientific Literature | ||
| 9. | ALA3057478 | F | Anti-inflammatory activity in Homo sapiens (human) T lymphocytes assessed as inhibition of PHA-induced [3H] thymidine uptake incubated for 72 hr prior to [3H]thymidine addition measured after 18 hr by liquid scintillation method | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 10. | ALA3057479 | F | Anti-inflammatory activity in Homo sapiens (human) T lymphocytes assessed as inhibition of PHA-induced [3H] thymidine uptake at 3.12 ug/ml incubated for 72 hr prior to [3H]thymidine addition measured after 18 hr by liquid scintillation method | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 11. | ALA3057480 | F | Anti-inflammatory activity in Homo sapiens (human) T lymphocytes assessed as inhibition of PHA-induced [3H] thymidine uptake at 12.5 ug/ml incubated for 72 hr prior to [3H]thymidine addition measured after 18 hr by liquid scintillation method | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 12. | ALA3057481 | F | Anti-inflammatory activity in Homo sapiens (human) T lymphocytes assessed as inhibition of PHA-induced [3H] thymidine uptake at 50 ug/ml incubated for 72 hr prior to [3H]thymidine addition measured after 18 hr by liquid scintillation method | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 13. | ALA3057482 | F | Antioxidant activity in Homo sapiens (human) whole blood assessed as inhibition of ROS production after 30 min by luminol-enhanced chemiluminescence assay | Homo sapiens | 4 | tissue-based format | Scientific Literature | ||
| 14. | ALA3057483 | F | Antioxidant activity in Homo sapiens (human) whole blood assessed as inhibition of ROS production at 12.5 ug/ml after 30 min by luminol-enhanced chemiluminescence assay | Homo sapiens | 4 | tissue-based format | Scientific Literature | ||
| 15. | ALA3057484 | F | Antioxidant activity in Homo sapiens (human) whole blood assessed as inhibition of ROS production at 50 ug/ml after 30 min by luminol-enhanced chemiluminescence assay | Homo sapiens | 4 | tissue-based format | Scientific Literature | ||
| 16. | ALA3057485 | F | Antioxidant activity in Homo sapiens (human) whole blood assessed as inhibition of ROS production at 100 ug/ml after 30 min by luminol-enhanced chemiluminescence assay | Homo sapiens | 4 | tissue-based format | Scientific Literature | ||
| 17. | ALA3057486 | F | Antifungal activity against Saccharomyces cerevisiae assessed as zone of inhibition at 5 to 40 ug/ml after 7 days by disk diffusion method relative to gatifloxacin | Saccharomyces cerevisiae | 4 | organism-based format | Scientific Literature | ||
| 18. | ALA3057487 | F | Antifungal activity against Saccharomyces cerevisiae assessed as concentration required to obtain a zone of inhibition of 40 mM after 7 days by disk diffusion method | Saccharomyces cerevisiae | 5 | organism-based format | Scientific Literature | ||
| 19. | ALA3057488 | F | Antifungal activity against Saccharomyces cerevisiae assessed as concentration required to obtain a zone of inhibition of 20 mM after 7 days by disk diffusion method | Saccharomyces cerevisiae | 5 | organism-based format | Scientific Literature | ||
| 20. | ALA3057489 | F | Antifungal activity against Fusarium solani assessed as zone of inhibition at 5 to 40 ug/ml after 7 days by disk diffusion method relative to gatifloxacin | Fusarium solani | 4 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!